AllNewsPhotosVideos
Serum Institute Of India

Serum Institute Of India

Serum institute of india, Latest News

Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966.The company is the world's largest vaccine producer by number of doses produced. It is currently developing an intra-nasal swine flu vaccine.
Read More
Adar Poonawalla: 'If fourth wave comes, it will be mild hopefully' - Hindi News | Adar Poonawalla: 'If fourth wave comes, it will be mild hopefully' | Latest national News at Lokmattimes.com

National :Adar Poonawalla: 'If fourth wave comes, it will be mild hopefully'

Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII) has made an important statement regarding the ... ...

Adar Poonawalla lauds Centre's work during COVID pandemic - Hindi News | Adar Poonawalla lauds Centre's work during COVID pandemic | Latest national News at Lokmattimes.com

National :Adar Poonawalla lauds Centre's work during COVID pandemic

Amid the overall cases and positivity rate declining in the country and states like Maharashtra, West Bengal and Himachal Pradesh revoking the COVID restrictions, Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII), prais ...

Nepal PM's India visit reflects age-old New Delhi-Kathmandu friendship - Hindi News | Nepal PM's India visit reflects age-old New Delhi-Kathmandu friendship | Latest international News at Lokmattimes.com

International :Nepal PM's India visit reflects age-old New Delhi-Kathmandu friendship

Nepal's Prime Minister Sher Bahadur Deuba's official visit to India from April 1 to 3 reflects Delhi and Kathmandu's old friendship which flourished back in 1950 when both countries came together and signed the India-Nepal Treaty of Peace and Friends ...

NTAGI to review Covovax data for use in 12-year olds and above - Hindi News | NTAGI to review Covovax data for use in 12-year olds and above | Latest health News at Lokmattimes.com

Health :NTAGI to review Covovax data for use in 12-year olds and above

New Delhi, March 30 The Covid working group of National Technical Advisory on Immunisation (NTAGI) will review the ... ...

NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources - Hindi News | NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources | Latest national News at Lokmattimes.com

National :NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources

The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday. ...

Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India - Hindi News | Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India | Latest international News at Lokmattimes.com

International :Novovax' COVID-19 vaccine gets emergency use authorisation for adolescents between 12-18 yrs in India

Novavax on Tuesday announced the first emergency use authorization of its COVID-19 vaccine for adolescents falling in the age bracket of 12-18 years in India. ...

DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years - Hindi News | DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years | Latest national News at Lokmattimes.com

National :DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 years

The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years. ...

SII provided COVID-19 vaccine at 'cost of cup of tea', saved nearly two-thirds of infant population: Cyrus Poonawala - Hindi News | SII provided COVID-19 vaccine at 'cost of cup of tea', saved nearly two-thirds of infant population: Cyrus Poonawala | Latest national News at Lokmattimes.com

National :SII provided COVID-19 vaccine at 'cost of cup of tea', saved nearly two-thirds of infant population: Cyrus Poonawala

Padma Bhushan-awardee and industrialist Cyrus Poonawala on Monday said Serum Institute of India (SI) provided COVID-19 vaccine at "the cost of a cup of tea" and saved nearly two-thirds infant population in the world. ...